Montauk Renewables (MNTK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 26, 2026, to be held virtually, with record date set as April 2, 2026.
Strategic progress in 2025 included increased RNG production at Pico and Apex facilities, and the GreenWave joint venture generated $1.5 million in income.
Commissioning of the Turkey, North Carolina facility began in 2026, with a $200 million capital investment and new $200 million Senior Credit Facility secured.
Five-year gas rights extension negotiated for the Raeger RNG facility.
Voting matters and shareholder proposals
Shareholders will vote on the election of two Class III directors for three-year terms and ratification of Grant Thornton LLP as independent auditor for 2026.
Board recommends voting FOR both director nominees and auditor ratification.
Voting instructions differ for Nasdaq and JSE shareholders; proxy materials are available online.
Board of directors and corporate governance
Board consists of six members divided into three staggered classes; two Class III directors up for election.
Board leadership is separated between CEO and Chairman, with an independent Lead Director.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Environmental, Safety and Corporate Responsibility (ESCR).
Controlled company exemption applies due to over 50% ownership by parties to a Consortium Agreement.
Board and committee meeting attendance exceeded 75% for all directors in 2025.
Latest events from Montauk Renewables
- Q2 2026 revenue rose 19.7% to $54M, with net income rebounding on strong RIN and JV contributions.MNTK
Q2 2026 - Director elections and auditor ratification approved; meeting adjourned after Q&A.MNTK
AGM 2026 - Q1 2026 revenue up 9%, net income positive, and new $200M credit facility secured.MNTK
Q1 2026 - Vote on two director nominees and auditor ratification at the May 2026 virtual Annual Meeting.MNTK
Proxy filing - Net income plunged on flat revenue as RIN prices fell, but 2026 guidance expects growth.MNTK
Q4 2025 - Q3 2024 revenue up 18.4% and net income up 31.8%, but project delays persist.MNTK
Q3 2024 - Q2 revenue dropped 18.6% on delayed RIN sales, but 2024 guidance and project pipeline remain strong.MNTK
Q2 2024 - Q1 2025 revenue up 9.8%, but net loss and regulatory delays challenge outlook.MNTK
Q1 2025 - Net income fell 34.9% to $9.7M on flat revenue, with 2025 RNG revenue guidance at $150–$170M.MNTK
Q4 2024